First Xontogeny Startup Landos Raises $10M to Develop Autoimmune Disease Drugs

Autoimmune disease therapeutics startup Landos Biopharma raised $10 million in a Series A financing round led by life science investment management firm Perceptive Advisors as the sole investor. Founded by serial entrepreneur Josep Bassaganya-Riera, Ph.D., Landos is also the first company to be shepherded by Chris Garabedian’s accelerator Xontogeny, which launched in March with a $25 million Series A pot, also secured from Perceptive Advisors.Blacksburg, VA-based Landos is developing a pre